Sientra (SIEN) Stock Price, News & Analysis

Company Overview

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides fat transfer systems; body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists, and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Irvine, California. On February 12, 2024, Sientra, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.

Key Stats

• Today's Range: N/A
• 50-Day Range: $0.17 to $0.68
• 52-Week Range: N/A
• Volume: 3.44 million shs
• Average Volume: 4.15 million shs
• Market Capitalization: $2.08 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

SIEN Stock Analysis - Frequently Asked Questions

How were Sientra's earnings last quarter?

Sientra, Inc. (NASDAQ:SIEN) released its earnings results on Wednesday, November, 10th. The medical instruments supplier reported ($0.80) earnings per share for the quarter, beating the consensus estimate of ($2.60) by $1.80. The medical instruments supplier had revenue of $19.62 million for the quarter, compared to analysts' expectations of $18.10 million.

When did Sientra's stock split?

Shares of Sientra reverse split on Monday, January 23rd 2023. The 1-10 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

What other stocks do shareholders of Sientra own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Sientra investors own include Meta Platforms (META), NVIDIA (NVDA), Inovio Pharmaceuticals (INO), Advanced Micro Devices (AMD), Alibaba Group (BABA), Pfizer (PFE) and Verizon Communications (VZ).

Company Calendar

• Last Earnings: 11/10/2021
• Today: 1/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: NASDAQ:SIEN
• CUSIP: N/A
• CIK: 1551693
• Web: www.sientra.com
• Phone: (805) 562-3500
• Fax: 805-562-8401
• Employees: 304
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): ($5.57)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $-73,310,000.00
• Net Margins: -65.93%
• Pretax Margin: -65.68%
• Return on Equity: N/A
• Return on Assets: -40.45%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 0.57
• Quick Ratio: 0.31

Sales & Book Value

• Annual Sales: $90.55 million
• Price / Sales: 0.00
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: ($0.04) per share
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 11,960,000
• Free Float: 11,775,000
• Market Cap: $2.08 million
• Optionable: Optionable
• Beta: 2.04